Sorbact® Technology: The power of safe wound infection management​

Based on a physical mode of action, Cutimed Sorbact safely removes bacteria to prevent and treat wound infection.

Image showing the Sorbact® Technology logo.

Sorbact® Technology

Sorbact Technology effectively prevents and treats wound infection across all ages, from children to the elderly. Developed with a physical mode of action, bacteria irreversibly bind to the DACC™-coated surface and are safely removed. Evidence has shown​ an antibacterial effect without the release of active substances, and therefore antimicrobial resistance is not expected. Sorbact Technology dressings deliver powerful, safe and effective wound infection management for the advancement of patient well-being.


  • The surface of Cutimed Sorbact has special characteristics and hydrophobic properties
  • Bacteria naturally bind and anchor to the unique DACC™-coated surface
  • Also binds endotoxins that may impair wound healing*
* In vitro data
Image showing an anchor icon, which stands for binding bacteria.


  • Bacteria are irreversibly bound and growth is inhibited
  • Endotoxins are shown not to be released from the bacteria*
  • Antimicrobial resistance is not expected

* In vitro data
Image showing a knot icon, which stands for inhibit bacteria.


  • Bound bacteria, fungi and endotoxins are safely removed
  • The bacterial load in the wound bed is reduced
  • Reduced bioburden supports natural wound healing
Image showing a hand that removes a dressing, which stands for removing bacteria.

Sorbact Technology benefits

Reduces the bioburden in wounds [1,2]
No release of active substances into the wound
Does not promote the bacterial release of endotoxins [3]
Development of bacterial or fungal resistance is not expected
No known contraindications and low risk of allergies
No limitation in treatment time [4]

No known antimicrobial resistance


Cutimed Sorbact is not only highly effective against common wound bacteria including MRSA [5] and VRE but also targets fungi.

With the Sorbact Technology mode of action, unlike certain antimicrobial substances that kill microbes, development of bacterial or fungal resistance is not expected, and with no limitation in treatment time.


  1. Mosti G et al. Comparative study of two antimicrobial dressings in infected leg ulcers: a pilot study. J Wound Care. 2015;24:121-122, 124-127. Read more 
  2. Ciliberti M et al. The effect of a bacteria- and fungi- binding mesh dressing on the bacterial load of pressure ulcers treated with negative pressure wound therapy: a pilot study. Wounds. 2016;28:408-420. Read more 
  3. Budi Susilo Y et al. Significant and rapid reduction of free endotoxin using a dialkylcarbamoyl chloride-coated wound dressing. J Wound Care. 2022;31:502-509. Read more 
  4. Kammerlander G et al. An investigation of Cutimed Sorbact as an antimicrobial alternative in wound management. Wounds UK. 2008; 4(2):10-18. Read more 
  5. Ronner AC et al. Adhesion of meticillin-resistant Staphylococcus aureus to DACC-coated dressings. J Wound Care. 2014;23:484, 486-488. Read more